INFI
Infinity Pharmaceuticals Inc
Price:  
0.04 
USD
Volume:  
22,131,812.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INFI WACC - Weighted Average Cost of Capital

The WACC of Infinity Pharmaceuticals Inc (INFI) is 5.8%.

The Cost of Equity of Infinity Pharmaceuticals Inc (INFI) is 8.00%.
The Cost of Debt of Infinity Pharmaceuticals Inc (INFI) is 5.00%.

Range Selected
Cost of equity 6.80% - 9.20% 8.00%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.2% - 6.4% 5.8%
WACC

INFI WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 0.52 0.66
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 9.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.2% 6.4%
Selected WACC 5.8%